Latest Ratings for IONS Date Firm Action From To Mar 2022 Guggenheim Initiates Coverage On Buy Mar 2022 Citigroup Initiates Coverage On Sell Feb 2022 SVB Leerink Maintains Market Perform View More Analyst Ratings for IONS View the Latest Analyst Ratings read more ​  ​Latest Ratings for IONS DateFirmActionFromTo Mar 2022GuggenheimInitiates Coverage OnBuy Mar 2022CitigroupInitiates

Latest Ratings for ABNB Date Firm Action From To Mar 2022 Deutsche Bank Initiates Coverage On Hold Mar 2022 Tigress Financial Maintains Buy Feb 2022 Citigroup Maintains Neutral View More Analyst Ratings for ABNB View the Latest Analyst Ratings read more ​  ​Latest Ratings for ABNB DateFirmActionFromTo Mar 2022Deutsche BankInitiates Coverage OnHold Mar 2022Tigress FinancialMaintainsBuy

read more ​  ​read more 

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the FDA to resolve issues. read more ​  ​Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the

read more ​  ​read more 

read more ​  ​read more 

Aurora’s international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter. read more ​  ​Aurora’s international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter. read more